Strategic Partnerships Partnership with Mark Cuban Cost Plus Drug Company signals openness to collaboration with disruptive medication access models. Leverage this to offer integrated cost-containment programs, co-branded affordability initiatives, and expanded access strategies for insured and self-funded groups.

Rapid Onboarding Ability to implement new groups in 30 days or less highlights streamlined implementation capabilities. Position as a selling point to brokers and clients seeking quick ROI, seamless transitions, and minimal downtime during benefits transitions.

Technology Enablement Tech stack including Power BI, Google Cloud, EMR integrations with ConfirmRx, and analytics tooling indicates strong data capabilities. Pitch data-driven benefit design, utilization management, and reporting services to brokers and health plans.

Affordability Focus Recent collaboration with Cost Plus Drug Company reinforces emphasis on cost-effective medication access. Explore opportunities to bundle PBM services with affordability programs, tiered formulary designs, and negotiating power for high-cost therapies.

Niche Focus Smaller to mid-size employer and broker market (private, 36+ years in operation) suggests opportunities to expand in independent groups and regional TPAs seeking personalized, flexible PBM solutions with attentive client service.